The PE Ratio as of September 2024 (TTM) for Nova Mentis Life Science Corp. (NMLSF) is -0.50

According to Nova Mentis Life Science Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.50. This represents a change of -88.90% compared to the average of -4.50 of the last 4 quarters.

Nova Mentis Life Science Corp. (NMLSF) Historical PE Ratio (quarterly & annually)

How has NMLSF PE Ratio performed in the past?

The mean historical PE Ratio of Nova Mentis Life Science Corp. over the last ten years is -213.96. The current -0.50 PE Ratio has changed -76.63% with respect to the historical average. Over the past ten years (40 quarters), NMLSF's PE Ratio was at its highest in in the December 2014 quarter at -0.19. The PE Ratio was at its lowest in in the June 2018 quarter at -159.37.

Nova Mentis Life Science Corp. (NMLSF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Nova Mentis Life Science Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nova Mentis Life Science Corp. (NMLSF) Average PE Ratio

How has NMLSF PE Ratio performed in the past?

The current PE Ratio of Nova Mentis Life Science Corp. (NMLSF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nova Mentis Life Science Corp. (NMLSF) PE Ratio vs. Peers

How is NMLSF’s PE Ratio compared to its peers?

Nova Mentis Life Science Corp.’s PE Ratio is greater than Awakn Life Sciences Corp. (-0.90), less than PsyBio Therapeutics Corp. (-0.01), less than HAVN Life Sciences Inc. (0), greater than Tryp Therapeutics Inc. (-2.10), less than Wesana Health Holdings Inc. (0), greater than BioVaxys Technology Corp. (-0.76), greater than GH Research PLC (-2.40), greater than Algernon Pharmaceuticals Inc. (-11.99), greater than AXIM Biotechnologies, Inc. (-0.92), less than Mind Cure Health Inc. (-0.50), greater than Surrozen, Inc. (-102.22), greater than Jasper Therapeutics, Inc. (-0.52), greater than Revelation Biosciences, Inc. (-5.52), less than Protagenic Therapeutics, Inc. (-0.09), greater than Sino Biopharmaceutical Limited (-0.51), less than ZIVO Bioscience, Inc. (14.41), greater than Cyteir Therapeutics, Inc. (-2.68), greater than Eledon Pharmaceuticals, Inc. (-3.52), greater than null (-1.45),

Build a custom stock screener for Nova Mentis Life Science Corp. (NMLSF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nova Mentis Life Science Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nova Mentis Life Science Corp. (NMLSF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nova Mentis Life Science Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.